CAPE TOWN: South Africa's pharmaceutical regulator SAHPRA said on Monday it has received its first application to register a COVID-19 vaccine from Johnson & Johnson.
Chief Executive of South African Health Products Regulatory Authority (SAHPRA) Boitumelo Semete told a news conference the regulator would focus on "safety, quality and efficacy" of a vaccine.
South Africa is currently the worst-hit country in the continent in terms of coronavirus infections and has entered a second wave.